Oruka Therapeutics Files Q1 2025 10-Q Report

Ticker: ORKA · Form: 10-Q · Filed: May 14, 2025 · CIK: 907654

Oruka Therapeutics, Inc. 10-Q Filing Summary
FieldDetail
CompanyOruka Therapeutics, Inc. (ORKA)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, pharmaceutical

TL;DR

Oruka Therapeutics filed its Q1 2025 10-Q. Check financials.

AI Summary

Oruka Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC, is incorporated in Delaware and headquartered in Menlo Park, California. The filing details its financial performance and business operations for the specified quarter.

Why It Matters

This filing provides investors and the public with an update on Oruka Therapeutics' financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Oruka Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Players & Entities

  • Oruka Therapeutics, Inc. (company) — Registrant
  • March 31, 2025 (date) — Quarterly period end date
  • ARCA biopharma, Inc. (company) — Former company name
  • NUVELO INC (company) — Former company name
  • HYSEQ INC (company) — Former company name
  • Delaware (jurisdiction) — State of incorporation
  • Menlo Park, California (location) — Business address
  • 000-22873 (identifier) — Commission file number

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the quarterly period ended March 31, 2025.

What is the commission file number for Oruka Therapeutics, Inc.?

The commission file number for Oruka Therapeutics, Inc. is 000-22873.

In which state is Oruka Therapeutics, Inc. incorporated?

Oruka Therapeutics, Inc. is incorporated in Delaware.

What is the business address of Oruka Therapeutics, Inc.?

The business address of Oruka Therapeutics, Inc. is 855 Oak Grove Avenue, Suite 100, Menlo Park, California 94025.

What were some of Oruka Therapeutics' former company names?

Oruka Therapeutics was formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Oruka Therapeutics, Inc. (ORKA).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.